Last updated on November 2018

OPTIMIZE IDE for the Treatment of ACS

Brief description of study

Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm

Clinical Study Identifier: NCT03190473

Contact Investigators or Research Sites near you

Start Over

Stijn Brinckman, MD

Tergooi Ziekenhuis
Blaricum, Netherlands
  Connect »

Bart de Smet, MD

Meander Medisch Centrum
Amersfoort, Netherlands
  Connect »